BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, January 15, 2026
Home » Authors » Nuala Moran

Articles by Nuala Moran

Archimedes Pharma Started As Nasal Drug Delivery Firm

Feb. 16, 2005
By Nuala Moran
LONDON - Three former Shire Pharmaceuticals Group plc executives have raised $7.1 million to acquire nasal drug delivery technology from West Pharmaceutical Services Inc. (WPS), along with $40 million for product development, as the foundation of a new company, Archimedes Pharma Ltd. (BioWorld International)
Read More

Like Biotech In General, Marine Biotechnology Has List Of Needs

Feb. 9, 2005
By Nuala Moran

Phytopharm's £23.9M Gives Company Bargaining Power

Feb. 9, 2005
By Nuala Moran

Phytopharm's £23.9M Gives Company Bargaining Power

Feb. 9, 2005
By Nuala Moran

Like Biotech In General, Marine Biotechnology Has List Of Needs

Feb. 9, 2005
By Nuala Moran

Report from Europe: New UK rules designed to deal with animal extremists

Feb. 8, 2005
By Nuala Moran

New UK Rules Designed To Deal With Animal Extremists

Feb. 2, 2005
By Nuala Moran

CAT Gaining Cash Via High Court Decision; Abbott Can Seek Appeal

Feb. 2, 2005
By Nuala Moran
LONDON - Cambridge Antibody Technology (CAT) Group plc received about £13.4 million (US$25 million) from Abbott Laboratories after the pharmaceutical company wasn't able to appeal a High Court judgment in CAT's favor and ordered to pay royalty arrears on sales of the blockbuster rheumatoid arthritis drug Humira. (BioWorld International)
Read More

New UK Rules Designed To Deal With Animal Extremists

Feb. 2, 2005
By Nuala Moran

CAT Gaining Cash Via High Court Decision; Abbott Can Seek Appeal

Feb. 2, 2005
By Nuala Moran
LONDON - Cambridge Antibody Technology (CAT) Group plc received about £13.4 million (US$25 million) from Abbott Laboratories after the pharmaceutical company wasn't able to appeal a High Court judgment in CAT's favor and ordered to pay royalty arrears on sales of the blockbuster rheumatoid arthritis drug Humira. (BioWorld International)
Read More
Previous 1 2 … 426 427 428 429 430 431 432 433 434 … 529 530 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 15, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 15, 2026.
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • Lung cancer illustration

    LINC01116 has prognostic value in lung cancer, study shows

    BioWorld MedTech
    Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
  • SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

    BioWorld Science
    Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing